Cost effectiveness acceptability curves for vaccination of girls aged 12 years with a quadrivalent vaccine at different levels of three dose coverage, for different assumptions about duration of protection from vaccine


Incremental cost effectiveness of vaccination compared with no vaccination option is shown. Region of £20 000-£30 000 per QALY gained is shaded<p><b>Copyright information:</b></p><p>Taken from "Economic evaluation of human papillomavirus vaccination in the United Kingdom"</p><p></p><p>BMJ : British Medical Journal 2008;337():-.</p><p>Published online 31 Jul 2008</p><p>PMCID:PMC2500202.</p><p></p

    Similar works

    Full text


    Available Versions